Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses

International Journal of Dermatology

Volumn 41, Issue 6, 2002, Pages 371-372

  Burkhart, Craig N ^a   Burkhart, Craig G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; ARACHIDONIC ACID; DICLOFENAC; DRUG VEHICLE; FLUOROURACIL; HYALURONIC ACID; IMMUNOMODULATING AGENT; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; STEROID; TACROLIMUS;

ACTINIC KERATOSIS; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; ENZYME INHIBITION; EVALUATION; GEL; HUMAN; LETTER; PATIENT COMPLIANCE; PROTEIN EXPRESSION; SKIN INFLAMMATION; WOUND HEALING IMPAIRMENT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG COMBINATIONS; GELS; HUMANS; HYALURONIC ACID; KERATOSIS; PHOTOSENSITIVITY DISORDERS;

EID: 0036332505     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01389.x     Document Type: Letter

References (6)

1. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
2. Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses
3. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: A double-blind crossover placebo-controlled study
4. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs
5. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use
6. Noninflammatory destruction of actinic keratosis by fluorouracil